
Please try another search
Shanghai Shyndec Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China. The company offers 6-APA, 7-ADCA, 7-ACA, D-7ACA, and penicillin industrial potassium; pharmaceutical intermediates, anti-infective pharmaceutical intermediates salt, and ceftriaxone sodium crude salt; and amoxicillin, clavulanic acid series, azithromycin, and ceftriaxone sodium. It also provides anti-infective pharmaceutical raw materials; urogenital system pharmaceutical raw materials, systemic anti-infective drugs; cardiovascular system medications; urogenital system medications and hormones; drugs for the nervous system; diclofenac sodium sustained-release tablets for musculoskeletal system; digestive tract and metabolism medications; anti-tumor and immunomodulatory agent; blood and hematopoietic system medications; respiratory system medications; animal vaccines; and general health products. Shanghai Shyndec Pharmaceutical Co., Ltd. was founded in 2000 and is based in Shanghai, China.
Name | Age | Since | Title |
---|---|---|---|
Shuyuan Wei | 61 | 2020 | Director |
Fanhong Wu | 57 | 2021 | Independent Director |
Yonggang Xing | 49 | 2019 | Chairman of the Supervisory Board |
Kan Tian | 62 | 2019 | Independent Director |
Yingqi Li | 49 | 2022 | Independent Director |
Yong Liu | 56 | 2021 | President & Director |
Yonghua Zuo | 49 | 2022 | Supervisor |
Hui Li | 36 | 2024 | Employee Supervisor |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review